1. Home
  2. FTRE vs ETG Comparison

FTRE vs ETG Comparison

Compare FTRE & ETG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • ETG
  • Stock Information
  • Founded
  • FTRE 1996
  • ETG 2003
  • Country
  • FTRE United States
  • ETG United States
  • Employees
  • FTRE N/A
  • ETG N/A
  • Industry
  • FTRE Medical Specialities
  • ETG Investment Managers
  • Sector
  • FTRE Health Care
  • ETG Finance
  • Exchange
  • FTRE Nasdaq
  • ETG Nasdaq
  • Market Cap
  • FTRE 1.4B
  • ETG 1.5B
  • IPO Year
  • FTRE N/A
  • ETG N/A
  • Fundamental
  • Price
  • FTRE $14.88
  • ETG $18.98
  • Analyst Decision
  • FTRE Hold
  • ETG
  • Analyst Count
  • FTRE 11
  • ETG 0
  • Target Price
  • FTRE $23.30
  • ETG N/A
  • AVG Volume (30 Days)
  • FTRE 1.2M
  • ETG 132.1K
  • Earning Date
  • FTRE 03-03-2025
  • ETG 01-01-0001
  • Dividend Yield
  • FTRE N/A
  • ETG 6.64%
  • EPS Growth
  • FTRE N/A
  • ETG N/A
  • EPS
  • FTRE N/A
  • ETG N/A
  • Revenue
  • FTRE $2,975,600,000.00
  • ETG N/A
  • Revenue This Year
  • FTRE N/A
  • ETG N/A
  • Revenue Next Year
  • FTRE $1.02
  • ETG N/A
  • P/E Ratio
  • FTRE N/A
  • ETG N/A
  • Revenue Growth
  • FTRE 2.80
  • ETG N/A
  • 52 Week Low
  • FTRE $14.27
  • ETG $14.08
  • 52 Week High
  • FTRE $41.02
  • ETG $18.34
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 34.60
  • ETG 51.67
  • Support Level
  • FTRE $14.88
  • ETG $18.90
  • Resistance Level
  • FTRE $15.83
  • ETG $19.23
  • Average True Range (ATR)
  • FTRE 0.69
  • ETG 0.17
  • MACD
  • FTRE 0.08
  • ETG 0.00
  • Stochastic Oscillator
  • FTRE 25.85
  • ETG 65.75

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund of Beneficial Interest

Eaton Vance Tax Advgd Gbl Div Inc Fd is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of aerospace and defense, capital markets, diversified telecommunication services, electrical equipment, biotechnology, banks, and other areas.

Share on Social Networks: